Search results for "MAb"

showing 10 items of 1716 documents

797 Infliximab in the Treatment of Pediatric Ibd: A Single Centre Experience

2010

Background and aims: The biological treatment of IBD acts on different stages of immunophysiopathological processes of the disease. We describe evolution and clinical response to Infliximab in paediatric patients affected by IBD diagnosed and followed at our centre. Methods: In the last triennial period at our Department of Paediatrics in Palermo 53 infusions of Infliximab were administrated to our patients affected by severe forms of IBD. All patients but one were affected by several forms of CD. Only one child was affected by U.C. associated to pyoderma gangrenosum. The total number of infusions were administrated according the ACCENT 1 study at a dose of 5 mg/Kg. All the infusions were p…

Drugmedicine.medical_specialtybusiness.industrymedia_common.quotation_subjectDiseasemedicine.diseaseInfliximabDiscontinuationSingle centreTolerabilityInternal medicinePediatrics Perinatology and Child HealthmedicinebusinessPyoderma gangrenosummedia_commonPaediatric patientsmedicine.drugPediatric Research
researchProduct

Dose adjustments and discontinuation in TNF inhibitors treated patients: when and how. A systematic review of literature.

2018

Objectives To review the available evidence concerning the possibility of discontinuing and/or tapering the dosage of TNF inhibitors (TNFi) in RA patients experiencing clinical remission or low disease activity. Methods A systematic review of the literature concerning the low dosage and discontinuation of TNFi in disease-controlled RA patients was performed by evaluation of reports published in indexed international journals (Medline via PubMed, EMBASE), in the time frame from 8 April 2013 to 15 January 2016. Results We analysed the literature evaluating the efficacy and the safety of two different strategies using TNFi, decreasing dosage or discontinuation, in patients experiencing clinica…

Drugmedicine.medical_specialtymedia_common.quotation_subjectMEDLINEArthritisEtanerceptDose-Response RelationshipArthritis Rheumatoid03 medical and health sciences0302 clinical medicineRheumatologyRheumatoidInternal medicinemedicineAdalimumabHumansPharmacology (medical)030212 general & internal medicinemedia_common030203 arthritis & rheumatologyDose-Response Relationship Drugbusiness.industryTumor Necrosis Factor-alphaArthritisRemission Inductionmedicine.diseaseRheumatologyAntirheumatic Agents; Arthritis Rheumatoid; Dose-Response Relationship Drug; Humans; Remission Induction; Tumor Necrosis Factor-alpha; Rheumatology; Pharmacology (medical)DiscontinuationRheumatoid arthritisAntirheumatic AgentsDrugbusinessmedicine.drugRheumatology (Oxford, England)
researchProduct

Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives.

2018

Approximately 5%-10% of asthmatics suffer from severe asthma. New biological treatments represent a great opportunity to reduce asthma burden and to improve asthma patients' lives. Reslizumab will soon be available in several European countries. This anti-IL-5 IgG4/kappa monoclonal antibody, administered intravenously at a dose of 3 mg/kg over 20-50 minutes every 4 weeks, has been shown to be safe and effective in patients with 400 eosinophils/mu L or more in their peripheral blood. The clinical effects in reducing asthma exacerbations and in improving the quality of life and lung function are clear, but further research is needed to determine the best biological compound for a specific clu…

Drugmedicine.medical_specialtymedia_common.quotation_subjectReview030204 cardiovascular system & hematologySettore MED/10 - Malattie Dell'Apparato Respiratoriopatient-reported outcomeasthma; patient-reported outcomes; personalized medicine; reslizumabPathogenesis030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineReslizumabInternal medicinemedicineAsthmatic patientPathologicalAsthmamedia_commonbusiness.industrypersonalized medicineasthmamedicine.diseasereslizumabpatient-reported outcomesPersonalized medicinebusinessMepolizumabmedicine.drugPatient related outcome measures
researchProduct

Assessing the risk to health care staff from long-term exposure to anticancer drugs--the case of monoclonal antibodies.

2010

Today the occupational health and safety risk involved when handling most anticancer drugs is well recognized and, as a result of regulatory requirements, safety measures have been established. There is little knowledge about the occupational hazard posed by handling monoclonal antibodies assigned to ATC Class L01XC. The aim of our study was to evaluate the occupational risk of monoclonal antibodies. Using the information obtained in a systematic review of the literature, the potentially dangerous properties of the active drug substances were assessed using a specially devised algorithm. As a result, all monoclonal antibodies in question were categorized as substances with developmental to…

Drugmedicine.medical_specialtymedicine.drug_classGemtuzumab ozogamicinmedia_common.quotation_subjectMEDLINEAntineoplastic AgentsMonoclonal antibodyRisk AssessmentOccupational safety and healthOccupational ExposureHealth caremedicineAnimalsHumansPharmacology (medical)Intensive care medicineOccupational Healthmedia_commonbusiness.industryAntibodies MonoclonalMolecular WeightOncologyHealth OccupationsImmunologyOccupational exposureRisk assessmentbusinessAlgorithmsmedicine.drugJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
researchProduct

Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab The…

2022

N/A

Dupilumab TherapyAntibodies Monoclonal Humanized; Disease Progression; Humans; Treatment Outcome; COVID-19; Dermatitis AtopicDermatitisAtopic dermatitis.DermatologyDupilumabAntibodies Monoclonal HumanizedAntibodiesAtopicDermatitis AtopicSettore MED/35MonoclonalImmunology and AllergyHumanshumanHumanizedAtopic dermatitistreatment outcome Antibodies Monoclonal HumanizedCOVID-19Treatment OutcomeCOVID-19 Dupilumab Therapydisease exacerbationDisease ProgressionSettore MED/35 - MALATTIE CUTANEE E VENEREEHumanmonoclonal antibody atopic dermatiti
researchProduct

A novel methodology for accelerating bitstream relocation in partially reconfigurable systems

2012

International audience; Xilinx Virtex FPGAs offer the possibility of Partial Reconfiguration (PR). Arbitrary tasks can be allocated and de-allocated onto FPGA without system interruption. However, mapping a task to any available PR region requires a unique partial bitstream for each partition, hence reducing memory storage requirements. In recent years, an interest on overcoming this problem has lead to the concept of Partial Bitstream Relocation (PBR). The principle is to perform bitstream modification to map it to different regions. However, PBR consumes scarce resources in hardware implementations, and introduces a prohibitive time overhead when done in software. In order to find the bes…

Dynamic Partial ReconfigurationComputer Networks and CommunicationsComputer scienceBitstream Relocation02 engineering and technology01 natural sciencesSoftwareArtificial Intelligence0103 physical sciences0202 electrical engineering electronic engineering information engineering[ INFO.INFO-ES ] Computer Science [cs]/Embedded SystemsBitstreamField-programmable gate arrayFPGA010302 applied physicsVirtexbusiness.industryControl reconfigurationPartition (database)020202 computer hardware & architecture[INFO.INFO-ES] Computer Science [cs]/Embedded SystemsHardware and ArchitectureEmbedded systemReconfigurable Computing[INFO.INFO-ES]Computer Science [cs]/Embedded SystemsbusinessRelocationEmbedded SystemsSoftware
researchProduct

Accelerating short read mapping on an FPGA (abstract only)

2012

The explosive growth of short read datasets produced by high throughput DNA sequencing technologies poses a challenge to the mapping of short reads to a reference genome in terms of sensitivity and execution speed. Existing methods often use a restrictive error model for computing the alignments to improve speed, whereas more flexible error models are generally too slow for large-scale applications. Although a number of short read mapping software tools have been proposed, designs based on hardware are relatively rare. In this paper, we present a hybrid system for short read mapping utilizing both software and field programmable gate array (FPGA)-based hardware. The compute intensive semi-g…

Dynamic programmingSpeedupSoftwareParallel processing (DSP implementation)Computer sciencebusiness.industryHybrid systemSensitivity (control systems)Parallel computingShort readbusinessField-programmable gate arrayProceedings of the ACM/SIGDA international symposium on Field Programmable Gate Arrays
researchProduct

Experimental Validation of a Novel Method for Harmonic Mitigation for a Three-Phase Five-Level Cascaded H-Bridges Inverter

2019

In modern high-power electrical drives, the efficiency of the system is a crucial constraint. Moreover, the efficiency of power converters plays a fundamental role in modern applications requiring also a limited weight, such as the electric vehicles and novel more electric aircraft. The reduction of losses pushes for systems with a dc bus and a high number of dc/ac converters, widespread in the vehicle, not burdened by a too expensive data processing system. The purpose of this article is to concur to reduce losses by proposing an innovative selective harmonic mitigation method based on the identification of the working areas where the reference harmonics present lower amplitudes. In partic…

Electric machineCascade systemsfield-programmable gate arraysinvertersmultilevel systemspower conversion harmonicsbusiness.product_categoryComputer science020208 electrical & electronic engineering02 engineering and technologyConvertersSettore ING-IND/32 - Convertitori Macchine E Azionamenti ElettriciSettore ING-INF/01 - ElettronicaIndustrial and Manufacturing EngineeringDC-BUSHarmonic analysisNonlinear systemSettore ING-IND/31 - ElettrotecnicaThree-phaseControl and Systems EngineeringHarmonics0202 electrical engineering electronic engineering information engineeringElectronic engineeringInverter020201 artificial intelligence & image processingElectrical and Electronic Engineeringbusiness
researchProduct

Remote diagnosis and control of wheelchair electrical drive systems

2005

A new Diagnostic and Protective System (DPS) suitable for wheelchair electrical drive applications has been prepared. Such a system is able to perform both monitoring and long-distance transmission of key signals that are used as pre-fault and fault indicators. The system, moreover, may detect several anomalous working conditions by means of reliable diagnosis procedures and carries out actions to protect the electrical drive and to drive the disabled people in safe conditions. In particular the design, the realization and the performance analysis of the new dedicated diagnostic system, which exploits a programmable logic controller (PLC) as DRS hardware, are described and discussed. The ef…

Electric motorEngineeringbusiness.industryelectric propulsionProgrammable logic controllerComputerApplications_COMPUTERSINOTHERSYSTEMSControl engineeringFault (power engineering)law.inventionRemote operationWheelchairwheelchairremote controllawtelediagnosticTeleoperationKey (cryptography)businessRemote control2004 IEEE International Conference on Industrial Technology, 2004. IEEE ICIT '04.
researchProduct

Real-Time Localization of Epileptogenic Foci EEG Signals: An FPGA-Based Implementation

2020

The epileptogenic focus is a brain area that may be surgically removed to control of epileptic seizures. Locating it is an essential and crucial step prior to the surgical treatment. However, given the difficulty of determining the localization of this brain region responsible of the initial seizure discharge, many works have proposed machine learning methods for the automatic classification of focal and non-focal electroencephalographic (EEG) signals. These works use automatic classification as an analysis tool for helping neurosurgeons to identify focal areas off-line, out of surgery, during the processing of the huge amount of information collected during several days of patient monitori…

ElectrodiagnòsticRemote patient monitoringComputer science02 engineering and technologyElectroencephalographylcsh:Technologylcsh:Chemistryepileptogenic focus03 medical and health sciences0302 clinical medicineClassifier (linguistics)0202 electrical engineering electronic engineering information engineeringmedicineGeneral Materials ScienceEpilepsy surgeryLatency (engineering)Field-programmable gate arrayInstrumentationThroughput (business)lcsh:QH301-705.5FPGAFluid Flow and Transfer Processesmedicine.diagnostic_testbusiness.industrylcsh:TProcess Chemistry and Technologyreal-time implementationepileptic eeg signal classificationGeneral EngineeringProcess (computing)Pattern recognitionelectroencephalogramlcsh:QC1-999Computer Science Applicationsfpgalcsh:Biology (General)lcsh:QD1-999lcsh:TA1-2040epileptic EEG signal classificationepilepsy020201 artificial intelligence & image processingEnginyeria biomèdicaArtificial intelligenceElectroencefalografiabusinesslcsh:Engineering (General). Civil engineering (General)030217 neurology & neurosurgerylcsh:Physics
researchProduct